XML 23 R4.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 56,754 $ 38,761
General and administrative 23,201 17,437
Total operating expenses 79,955 56,198
Loss from operations (79,955) (56,198)
Other income (expense):    
Research and development incentives 2,807 3,084
Investment income 916 2,424
Interest expense on finance lease liability (2,242) (1,185)
Interest expense on debt obligations (818) (734)
Loss on extinguishment of debt (913)  
Other (expense) income (665) (16)
Total other (expense) income, net (915) 3,573
Net loss attributable to common stockholders $ (80,870) $ (52,625)
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) $ (1.75) $ (1.54)
Weighted average common shares outstanding, basic and diluted (in shares) 46,248,969 34,261,548